Summary
There are no ideal radioactive diagnostic or therapeutic agents. There is only the best compromise at a given time between the agent’s physical, chemical, and biological characteristics, its compatibility with available instrumentation needed for its use, and the ability to assure quality and availability. This article elaborates on the parameters affecting such compromise.
This is a preview of subscription content, log in via an institution to check access.
References
Anger H. O.: Scintillation Camera — Rev. sci. Instr.29, 27, 1958.
Barbizet J., Duizabo Ph., Thomas J., Galle P., Moretti J.-L., Pitton R.: La cisternographie et la ventriculographie isotopiques — Nouv. Presse méd.1, 2899, 1972.
Broser I., Kallmann H.: Über den Elementarprozess der Lichtanregung in Leuchtstoffen durch α-Teilchen, schnelle Elektronen und γ-Quanten II — Naturforschung2a, 642, 1947; see also2a, 439, 1947.
Cassen B., Curtis L., Reed C., Libby R.: Instrumentation for131I Use in Medical Studies — Nucleonics9, 46, 1951.
Joliot F., Curie I.: Artificial Production of a New Kind of Radio-Element — Nature (Lond.) February 10, 1934; p. 201.
Lin T. H., Khentigan A., Winchell H. S.: A99mTc-Chelate Substitute for Organoradiomercurial Renal Agents — J. nucl. Med.15, 34, 1974.
Lin M., Winchell H. S.: Kinetics of Amino Acid Transport across Bone Marrow Cell Membranes — J. clin. Invest.49, 752, 1970.
Myers W. G.: Radioisotopes of Iodine — In:Andrews G. A., Kniseley R. M., Wagner H. N., Jr. (Eds): Radioactive Pharmaceuticals. Proc. Symp. Oak Ridge Inst. Nuclear Studies, Conf. 651111, 1965; p. 217.
Wagner H. N., Jr.,Emmons H.: Characteristics of an Ideal Radiopharmaceutical — In:Andrews G. A., Kniseley R. M., Wagner H. N., Jr. (Eds): Radioactive Pharmaceuticals. Proc. Symp. Oak Ridge Inst. Nuclear Studies, Conf. 651111, 1965; p. 1.
Winchell H. S.: Dosimetry Considerations for Radioactive Labeled Organic Compounds — In:Cloutier R. J., Edwards C. L., Snyder W. S. (Eds): Medical Radionuclides: Radiation Dose and Effects. Oak Ridge Ass. Universities, 1969.
Winchell H. S., Pollycove M., Kusubov N., Fawwaz R.: Kinetics of131I Albumin and131I Transferrin in Lymph — In:Sirchis J. (Ed.): Proc. Int. Symp. on the Preparation and Biomedical Application of Labeled Molecules. Venezia, Italy, 1964.
Winstead M. B., Lamb J. F., Winchell H. S.: Relationship of Chemical Structure toin Vivo Scintigraphic Distribution Patterns of11C Compounds. I.11C-Carboxylates — J. nucl. Med.14, 747, 1973.
Winstead M. B., Lin T. H., Khentigan A., Lamb J. F., Fleischer A. A., Winchell H. S., Myers W. G.: Synthesis and Evaluation of11C-Labeled Organic Compounds for Use in Nuclear Medicine — In: Radiopharmaceuticals and Labelled Compounds. International Atomic Energy Agency, Vienna, 1973; vol. 1, p. 451.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winchell, H.S. Decision-making considerations in the choice of radioactive diagnostic and therapeutic agents. La Ricerca Clin. Lab. 7, 255–270 (1977). https://doi.org/10.1007/BF02881821
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02881821